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Purpose. To investigate potential associations between intraocular pressure (IOP) and cerebrospinal ﬂuid pressure (CSFP) in
patients with primary open-angle glaucoma (POAG) and healthy subjects. Methods. Forty-three subjects were recruited. Weight
and height were measured to calculate body mass index (BMI), along with blood pressure, heart rate, visual acuity, and IOP.
Biometrics exam, corneal pachymetry, peripapillary retinal nerve ﬁber layer (RNFL) thickness, and macular thickness were
assessed. )e visual ﬁeld exam was performed on all patients, and both pattern standard deviation (PSD) and mean deviation
(MD) were considered. CSFP was estimated indirectly by using the mathematical formula CSFP� 0.44×BMI+ 0.16× diastolic
pressure − 0.18× age − 1.91, based on the previous scientiﬁc studies. )e TLCPD was calculated as follows: IOP− CSFP. Results. A
signiﬁcant (p< 0.05) diﬀerence was found between the two groups for several parameters. Speciﬁcally, the CSFP was lower in
patients with POAG than in healthy subjects (8.14± 4.52 and 7.43± 2.06, p< 0.001, respectively). Anamnestic TLCPD was found
to be signiﬁcantly (p< 0.001) higher in patients with POAG compared to healthy subjects. A signiﬁcant (p< 0.05) correlation was
found between anamnestic TLCPD andMD (r� − 0.31), inferior RNFL thickness (r� − 0.29), superior RNFL thickness (r� − 0.27),
IOP (r� 0.22), and CSFP (r� − 0.46). Conclusion. )e CSFP was lower in glaucomatous patients compared to healthy subjects,
whereas the TLCPD was higher in glaucomatous patients compared to healthy subjects, even though this diﬀerence was not
statistically signiﬁcant. A higher TLCPD may damage the RNFL, resulting in functional visual ﬁeld impairment.
1. Introduction
)e term glaucoma comprises a heterogeneous group of
diseases with some characteristic features, including struc-
tural optic nerve head (ONH) damage and visual ﬁeld loss. It
has been proven that high intraocular pressure (IOP) is a risk
factor for glaucoma, and that lowering IOP can decelerate
disease progression [1]. However, increased IOP is not
necessary for the development of glaucoma as the charac-
teristic features of glaucoma may occur in susceptible
subjects at any IOP [2].)is suggests that high IOP is not the
sole risk factor for the development of glaucoma.
Other risk factors for glaucoma indicated in previous
studies include age, decreased central corneal thickness,
race, familial history of glaucoma, reduced ocular blood
ﬂow, low blood pressure, myopia, and lower ocular perfu-
sion pressure [3–5]. Each risk factor is known to be asso-
ciated with apoptotic processes that lead to glaucomatous
optic neuropathy [6–9].
Many recent studies have reported that cerebrospinal
ﬂuid pressure (CSFP) and translamina cribrosa pressure
diﬀerence (TLCPD) have a potential role in the pathogenesis
of glaucomatous optic neuropathy [10–13]. )e lamina
cribrosa is positioned on the bottom of the scleral canal to
close this hole, through which retinal ganglion cell axons exit
the eye and form the ONH. Both the ONH and lamina
cribrosa thus serve as barriers between intraocular and
retrobulbar compartments. In the retrobulbar compartment,
the optic nerve is surrounded by cerebrospinal ﬂuid (CSF) in
the subarachnoid space [11]. )erefore, on one side of the
lamina cribrosa exists an IOP and on the other side of the
laminar cribrosa exists a CSFP. )e diﬀerence between these
two pressures, IOP and CSFP, is the TLCPD. It has been
postulated that a high TLCPD may damage and lead to
abnormal functioning of the ONH due to changes in axonal
transport and deformation of the lamina cribrosa [10–14].
Although many studies have shown that CSFP and the
TLCPD seem to play a role in primary open-angle glaucoma
(POAG), little is known about other parameters involved in
the pathogenesis of glaucoma and those that may aﬀect
CSFP and TLCPD are age, blood pressure, body mass index
(BMI), IOP, central corneal thickness (CCT), and structural
and perimetric parameters [15].
)e purpose of this study was therefore to evaluate the
relationship between IOP and CSFP, as well as systemic and
ocular parameters in healthy and glaucomatous subjects.
2. Materials and Methods
)is research is a prospective study that has been approved
by the Institutional Review Board of University Policlinic
SanMartino, Genoa, Italy, and was conducted in accordance
with the principles of the Declaration of Helsinki. Patients
joined the study after having signed a written informed
consent. All subjects recruited for this study were selected at
the Eye Clinic of University Policlinic San Martino, Genoa,
Italy. All the clinical measurements were performed during
the morning clinical session between 9.00 am and 12.00 am.
)e study included forty-three subjects (26 POAG pa-
tients and 17 healthy subjects). All patients were questioned
about their demographics, clinical history, ophthalmic
history and ophthalmic medications, and systemic diseases
and systemic medications. All participants underwent
measurements of height (m), weight (kg), heart rate (HR)
(bpm), and blood pressure (mmHg) in a standardized
manner. Arterial hypertension was deﬁned as a systolic
blood pressure (SBP)> 140mmHg, and/or a diastolic blood
pressure (DBP)> 90mmHg, and/or self-reported current
treatment for arterial hypertension with antihypertensive
medications. BMI was calculated using the formula body
mass divided by the square of the body height and expressed
in units of kg/m2.
)e ophthalmic examination included measurements of
visual acuity (VA), measurements of IOP using a calibrated
Goldmann applanation tonometer, and slit-lamp exami-
nation of the anterior segment including gonioscopy and
fundus. Biometric examination with IOLMaster (Carl Zeiss
Meditec Inc., Dublin, California, USA) evaluated axial
length (AL) (mm), anterior chamber depth (ACD) (mm),
and corneal curvature (degrees). All patients underwent a
spectral domain optical coherence tomography (SD-OCT)
examination with RTVue SD-OCT (Optovue, Inc., Fremont,
California, USA), in order to evaluate the thickness of the
peripapillary retinal nerve ﬁber layer (RNFL), the foveal
thickness (microns), and CCT (microns). )e Humphrey
24-2 Swedish interactive threshold algorithm standard pe-
rimeter (Carl Zeiss Meditec Inc., Dublin, California, USA)
was used to evaluate the visual ﬁeld. To estimate the CSFP, a
formula cited in Xie et al.’s study was used:
CSFP�BMI× 0.44 + 0.16× diastolic BP − 0.18×AGE − 1.91
[15–17]. When this formula was tested on an independent
study group, it revealed that the measured CSFP did not
diﬀer signiﬁcantly (p � 0.29) from the calculated CSFP
(12.6mmHg vs. 13.3mmHg, respectively); [15–17] however,
the formula hypothesized that the orbital subarachnoid
space width, as measured by orbital MRI, can be used to
estimate the CSFP.
Furthermore, the TLCPD was calculated as IOP− CSFP.
Both current and anamnestic TLCPD were calculated by
using the data on the patients’ ﬁles. For the anamnestic data,
we used the information collected at the ﬁrst visit, and when
missed, we used younger data found in the ﬁle, but not the
data of the last visit.
)e recruited participants were classiﬁed into two
subsets: POAG patients (n� 26) and healthy subjects
(n� 17).
POAG eyes were diagnosed based upon having a re-
producible and characteristic visual ﬁeld defect of 3 nonedge
points which were all depressed on the pattern deviation plot
at p< 5%, along with an asymmetrical cupping greater than
0.2, the presence of a notch on the rim, and/or an increased
cupping greater than 0.6 at fundoscopy. Reliable tests had
fewer than 20% ﬁxation losses and less than 15% false-
negative and false-positive responses.
Healthy subjects had normal visual ﬁeld and optic disc in
accordance with IOP <21mmHg.
Exclusion criteria included history of active or past
ophthalmological diseases other than glaucoma such as
uveitis, maculopathy, corneal abnormalities (keratoconus or
corneal dystrophies), any history or slit-lamp evidence of
angle-closure glaucoma, history of ocular surgery or laser
treatments, history of ocular trauma, use of systemic ste-
roids, any other systemic medication known to aﬀect the
retina, any neurological condition known to aﬀect the visual
ﬁeld, and previous history of brain surgery that would aﬀect
the pressure and structural changes of the optic nerve.
3. Statistical Analysis
)e data were evaluated by descriptive analysis. When the
distribution of the data was normal, a two-tailed paired t-test
was used. When the distribution of the data was nonnormal,
a Mann–Whitney test was used. Pearson correlation co-
eﬃcient was used to analyze the correlations among all the
parameters. A p value <0.05 was considered statistically
signiﬁcant. A multivariate analysis was performed to verify
the eﬀect of age, gender, and BMI on the correlation studied.
4. Results
)e descriptive parameters measured in the POAG and
healthy group are summarized in Table 1. Of the 26 patients
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enrolled with a diagnosis of POAG, 12 were female and 14
were male, aged between 54 and 84 years (mean average age:
72.3± 7.7 years). )e results obtained were compared with
17 healthy subjects, 8 female and 9 male, aged between 42
and 89 (mean average age: 68.1± 15.6 years).
In the POAG group, 18 patients were suﬀering from high
blood pressure treated pharmacologically and one of these
patients was also suﬀering from noninsulin dependent di-
abetes mellitus (NIDDM) treated with glibenclamide.
In the healthy group, one subject had a positive family
history of glaucoma and 8 subjects were suﬀering from high
blood pressure treated pharmacologically. Of these, 4 were
suﬀering from cataracts (2 right eyes and 2 left eyes) and one
was suﬀering from NIDDM. Of the healthy patients without
hypertension or positive family history of glaucoma, 6 were
aﬀected by cataracts solely in the left eye, and one patient had
previously had an acute attack of glaucoma in the right eye,
so we considered only the left one. Lastly, another non-
hypertensive healthy patient without positive family history
of glaucoma was suﬀering from NIDDM treated with
glibenclamide.
As shown in Table 1, the parameters that diﬀer signif-
icantly between the glaucoma and healthy groups were age,
CSFP, anamnestic IOP, anamnestic TLCPD, MD, and PSD
(p< 0.001); VA, refractive error, and superior RNFL
thickness (p � 0.001); weight (p value between 0.001 and
0.01); and height and inferior RNFL thickness (p value
between 0.01 and 0.05).
Tables 2 and 3 summarize Pearson’s r correlation co-
eﬃcients performed to assess possible correlations between
all considered parameters. When a multivariate analysis was
performed, age, gender, and BMI did not have signiﬁcant
eﬀect on the considered parameters such as MD, PSD,
RNFL, foveal thickness, and TLCPD.
5. Discussion
Discussions about CSFP’s importance to the ONH and, in
particular, its potential role in the pathogenesis of glau-
comatous optic neuropathy have been ongoing for 40 years,
beginning with Volkov in 1976 [18], followed by Morgan
et al. in 1995 [19] and many others. Recently, Ren et al. [20]
found that in open-angle glaucoma with normal IOP, CSFP
is abnormally low, leading to an abnormally high trans-
lamina cribrosa pressure diﬀerence. )ey suggested that a
low CSFP in normal-IOP glaucoma may be similar to a high
IOP in high-IOP glaucoma. Depending on the posture, the
average IOP is higher than the average CSFP, impinging on
the TLCPD. A normal IOP with a low CSFP results in the
same TLCPD as patients who have an elevated IOP but
normal CSFP [21].)e pressure gradient through the lamina
cribrosa can be deﬁned as the distance between the in-
traocular compartment and the retrobulbar one, that is, the
thickness of the lamina cribrosa [10]. It has been shown that
the cribriform plate is thinner in patients who have glau-
comatous damage of the optic nerve. However, curiously,
experimental studies have also found that the cribriform
plate is thicker in the early stages of glaucoma [11, 12]. )e
changes of the TLCPD may explain the altered function and
optic nerve damage in relation to changes in axonal
transport and deformation of the lamina cribrosa in glau-
coma patients.
)e aim of our study was to investigate the relationship
between CSFP and IOP, as well as other systemic and ocular
Table 1: Descriptive statistics for glaucomatous and nonglaucomatous patients.
Glaucoma (n� 53) Normal (n� 33) Comparison test
Mean Standard deviation Mean Standard deviation p value
Age (years) 72.32 7.67 68.13 15.59 <0.001
Systolic blood pressure (mmHg) 124.91 15.24 130 16.22 0.986
Diastolic blood pressure (mmHg) 71.32 9.10 71.88 9.81 0.425
Height (m) 1.65 0.09 1.68 0.11 0.024
Weight (Kg) 67.45 10.98 70.69 21.57 0.004
BMI (kg/m2) 24.87 3.17 24.58 5.32 0.085
Heart rate (bpm) 66.26 11.04 66.88 11.02 0.745
Visual acuity (10/10) 9.4 1.43 8.12 2.29 0.001
Refractive error (diopters) 1.22 1.81 − 3 5.196 0.001
IOP (mmHg) 15.85 2.73 15.18 1.62 0.208
Anamnestic IOP (mmHg) 21.04 5.71 15 1.97 <0.001
CSFP (mmHg) 7.43 2.06 8.14 4.52 <0.001
Axial length (mm) 23.68 1.58 24.09 1.99 0.542
Anterior chamber depth (mm) 2.76 0.78 2.49 0.58 0.585
CCT (um) 534.21 36.09 552.69 30.96 0.210
Superior RNFL thickness (um) 83.06 13.29 94.75 6.05 0.001
Inferior RNFL thickness (um) 79.83 13.97 91.63 7.68 0.013
Foveal thickness (um) 253.11 29.06 272.69 30.15 0.862
MD (dB) − 3.59 4.72 − 0.47 0.72 <0.001
PSD (dB) 4.32 4.33 1.57 0.43 <0.001
TLCPD (mmHg) 8.42 3.27 7.51 3.47 0.235
Anamnestic TLCPD (mmHg) 13.61 6.18 7.33 3.97 <0.001
n�number of eye; BMI� body mass index; IOP� intraocular pressure; CSFP� cerebrospinal ﬂuid pressure; CCT�central corneal thickness; RNFL� retinal
nerve ﬁber layer; MD�mean deviation; PSD� pattern standard deviation; TLCPD� translamina cribrosa pressure diﬀerence.
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parameters in healthy and glaucomatous subjects. Patients
with POAG were found to have a statistically lower CSFP
compared to healthy patients (p< 0.001, Table 1). Both the
current and anamnestic TLCPD were higher in glaucoma
patients compared to healthy controls, but while the diﬀer-
ence of TLCPD was not signiﬁcant (p � 0.235), anamnestic
TLCPD was statistically signiﬁcant (p< 0.001, Table 1). )is
could be due to the IOP values used: indeed when no sig-
niﬁcant diﬀerence was found, the IOP measured was under
topical treatment.)ere are numerous studies in the literature
that deal with the relationship between CSFP, TLCPD, and
IOP and their direct consequences on the physiology of the
eye. In 2015, Jonas et al. outlined that the cerebrospinal ﬂuid
space extends from the intracranial compartment, through
the tiny optic canal, and ends posterior to the eyeball [9].
)erefore, the pressure of the orbital portion of the optic
nerve is not equal to the real orbital pressure (about 2mmHg),
but is at least as high as the CSFP. )is anatomical re-
lationship could have profound importance for the physi-
ology and pathophysiology of the optic disc, which acts as a
barrier between the intraocular and the retrobulbar com-
partments.)eTLCPD, which is determined by the diﬀerence
between the IOP and CSFP, is known to play a direct role in
the damage of the optic nerve head [9]. In 2008, the retro-
spective study of Berdahl et al. showed the CSFP of glau-
comatous and nonglaucomatous patients who underwent
lumbar puncture [13], and the authors found that CSFP was
signiﬁcantly lower in the group of patients with glaucoma
compared to the nonglaucomatous control group. Another
larger retrospective study performed by Berdahl et al. in 2008
upheld the results of their previous study, but also found that
patients with ocular hypertension had a signiﬁcantly elevated
intracranial pressure compared to the control group [22].
Although the studies from Berdahl et al. were limited by
small samples of patients, their ﬁndings suggested that
glaucomatous optic neuropathy was associated with low
CSFP, while ocular hypertension was associated with high
CSFP [13, 22]. Other studies, like the Beijing Eye Study [14]
and Central India Eye Study [23], instead of directly mea-
suring CSFP, estimated it by applying the formula developed
by Xie et al. in 2013 (CSFP� 0.44×BMI+ 0.16× diastolic
pressure − 0.18× age − 1.91), as we did in our study [15].
Similarly, in 2016, Siaudvytyte et al., utilizing two-depth
transcranial Doppler technology to noninvasively measure
CSFP and ocular perfusion pressure in patients with normal
tension glaucoma (NTG), found that patients with lower
intracranial pressure (ICP) had both more pronounced
structural damage and worsened ocular hemodynamic levels
[24]. )e same authors examined the diﬀerences in the
TLCPD and neuroretinal rim area (NRA) between patients
with NTG, with high-tension glaucoma, and healthy subjects
and found that there was a correlation between NRA and
TLCPD solely in the NTG group (r� − 0.83, p � 0.01), which
conﬁrmed the idea that decreased ICP produces increased
TLCPD and leads to glaucomatous damage [25]. )ese
studies, despite their wide geographical, cultural, social, and
economic diﬀerences of the studied subjects, uphold pre-
vious results and the results of our study, demonstrating that
patients with glaucoma have a lower estimated CSFP.
As shown in Table 1, compared to healthy subjects,
POAG patients also diﬀer signiﬁcantly in age, IOP, RNFL
thickness, PSD, height, and weight (all p values <0.05,
Table 1), but these diﬀerences were not active on the cor-
relation as multivariant analysis shows. Concerning the
association between measurements, we found a signiﬁcant
association (all p values <0.05, Tables 2 and 3) between
anamnestic TLCPD and weight (r� − 0.299), superior
(r� − 0.273) and inferior (r� − 0.294) RNFL thickness, and
MD (r� − 0.319) (Tables 2 and 3) and other parameters which
were included in the formula such as age (r� 0.269), BMI
(r� − 0.356), IOP (r� 0.223), and CSFP (r� − 0.456). Im-
portantly, the negative correlation between anamnestic
Table 2: Pearson’s correlation coeﬃcients (r) values.
CSFP TLCPD Anamnestic TLCPD AL ACD Foveal thickness CCT
Age − 0.653∗∗ 0.471∗∗ 0.269∗ − 0.289∗∗ 0.063 − 0.138 − 0.015
Systolic BP 0.317∗∗ − 0.093 − 0.161 − 0.127 − 0.430∗∗ 0.241∗ 0.128
Diastolic BP 0.501∗∗ − 0.229∗ − 0.134 − 0.068 − 0.308∗∗ 0.345∗∗ − 0.106
Height 0.177 − 0.072 − 0.065 0.456∗∗∗ 0.259∗ 0.041 0.046
Weight 0.487∗∗ − 0.399∗∗ − 0.299∗∗ 0.240∗ 0.094 − 0.163 0.234∗
BMI 0.530∗∗ − 0.489∗∗ − 0.356∗∗ − 0.044 − 0.116 − 0.258∗ 0.291∗∗∗Signiﬁcant p value <0.05, and ∗∗signiﬁcant p value ≤0.01. BP� blood pressure; BMI� body mass index; CSFP� cerebrospinal ﬂuid pressure;
TLCPD� translamina cribrosa pressure diﬀerence; AL� axial length; ACD� anterior chamber depth; CCT�central corneal thickness.
Table 3: Pearson’s correlation coeﬃcients (r) values.
CSFP TLCPD Anamnestic TLCPD SUP RNFLT INF RNFLT MD PSD
IOP 0.131 0.600∗∗ 0.223∗ 0.065 − 0.103 0.130 − 0.147
CSFP 1 − 0.714∗∗ − 0.456∗∗ 0.097 0.154 0.075 − 0.109
TLCPD − 0.714∗∗ 1 0.526∗∗ − 0.031 − 0.196 0.051 − 0.039
Anamnestic TLCPD − 0.456∗∗ 0.526∗∗ 1 − 0.273∗ − 0.294∗∗ − 0.319∗ 0.218
SUP RNFLT 0.097 − 0.031 − 0.273∗ 1 0.715∗∗ 0.446∗∗ − 0.466∗∗
INF RNFLT 0.154 − 0.196 − 0.294∗∗ 0.715∗∗ 1 0.390∗∗ − 0.462∗∗∗Signiﬁcant p value< 0.05, and ∗∗signiﬁcant p value ≤0.01. IOP� intraocular pressure; CSFP� cerebrospinal ﬂuid pressure; TLCPD� translamina cribrosa
pressure diﬀerence; SUP RNFLT�superior retinal nerve ﬁber layer thickness; INF RNFLT� inferior retinal nerve ﬁber layer thickness; MD�mean deviation;
PSD� pattern standard deviation.
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TLCPD and RNFL thickness agrees with the results pre-
viously reported by Siaudvytyte et al. [25] who found a
negative correlation between NRA and TLCPD in NTG
patients. )ese data could suggest a possible relationship
between TLCPD and the loss of ganglion cells evaluated as
RNFL thickness. It is also important the correlation between
anamnestic TLCPD and MD, which outlined the possible
relationship with the ONH function detected by perimetry.
)ese results are particularly signiﬁcant when con-
sidering the data from the literature concerning the well-
known risk factors for glaucoma onset and progression.
)e literature consistently shows that increasing IOP and
age are the major risk factors for the development and
progression of glaucoma [1]. Similarly, the RNFL is con-
sistently thinner and PSD higher among glaucoma patients
and these two measurements represent strong diagnostic
structural and functional tools for the disease [26]. )e
literature demonstrates conﬂicting results regarding the
relationship between BMI and glaucoma [27, 28]. In our
study, however, a signiﬁcant correlation was found between
BMI and anamnestic TLCPD (Table 2). Taken together, our
ﬁndings suggested that glaucomatous optic nerve damage
can be the result of a complex relationship between several
risk factors, which are all associated with TLCPD in our
study.
Our results have two main limitations: Firstly, the
sample size of our study was small (53 eyes of 26 patients
with POAG and 33 eyes of 17 healthy subjects) and consists
solely of Caucasian patients. )e results may not be
transferable across all populations, and further studies
should be conducted with larger sample sizes. Moreover,
we also used a calculation to indirectly calculate the CSFP,
which may not equal the true orbital CSFP [23]. However,
unlike previous studies regarding CSFP and glaucoma as in
Berdahl et al.’s retrospective studies, our study is a pro-
spective one, which limits the potential for confounding
variables and biases [13, 22].
In conclusion, this study showed that the estimated CSFP
was signiﬁcantly lower in POAG patients compared to the
control group, whereas the TLCDP in POAG patients was
higher, even if the diﬀerence was not statistically signiﬁcant,
than in the control group, but clinically, the data of anam-
nestic TLCDP were more useful and showed both signiﬁcant
diﬀerence between the two groups and good correlation with
other clinical parameters. )ese results agree with previous
studies. )e CSFP may lead to stress on the peripapillary
RNFL, as demonstrated by the RNFL values. As a result,
patients will have corresponding functional damage, detect-
able by the values of MD and PSD in perimetry. )erefore,
our ﬁndings suggested that orbital CSFP was a counter-
pressure to IOP and was an important determinant of
TLCPD, the pathophysiology and physiology of the optic
nerve head, and pressure-related diseases, such as glaucom-
atous optic neuropathy.
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